J Vet Sci.  2020 May;21(3):e35. 10.4142/jvs.2020.21.e35.

Allometric analysis of tylosin tartrate pharmacokinetics in growing male turkeys

• Poźniak B
• Tikhomirov M
• Motykiewicz-Pers K
• Bobrek K
• Świtała M

• KMID: 2502379
• DOI: http://doi.org/10.4142/jvs.2020.21.e35

Abstract

Background
Despite common use of tylosin in turkeys, the pharmacokinetic (PK) data for this drug in turkeys is limited. Within a few months of growth, PK of drugs in turkeys undergoes changes that may decrease their efficacy due to variable internal exposure.
Objectives
The objective of this study was to investigate the influence of age on the PK of a single intravenous (i.v.) and oral administration of tylosin to turkeys at a dose of 10 and 50 mg/kg, respectively.
Methods
Plasma drug concentrations were measured using high-performance liquid chromatography with UV detection. The PK parameters were assessed by means of non-compartmental approach and were subjected to allometric analysis.
Results
During a 2.5-month-long period of growth from 1.4 to 14.7 kg, the median value for area under the concentration-time curve after i.v. administration increased from 2.61 to 7.15 mg × h/L and the body clearance decreased from a median of 3.81 to 1.42 L/h/kg. Over the same time, the median elimination half-life increased from 1.03 to 2.96 h. For the oral administration a similar trend was noted but the differences were less pronounced. Bioavailability was variable (5.76%–21.59%) and age-independent. For both routes, the plasma concentration of the major tylosin metabolite, tylosin D, was minimal. Protein binding was age-independent and did not exceed 50%. Allometric analysis indicated a relatively poor predictivity of clearance, volume of distribution and elimination half-life for tylosin in turkeys.
Conclusions
Age has a significant impact on tylosin PK in turkeys and dosage adjustment may be needed, particularly in young individuals.

Keyword

Tylosin; Turkey; allometry; pharmacokinetics; growth